How to Increase Access Cancer Drugs Discussed at NCCN Meeting
(Medscape Medical News) Sept 25, 2018 - A National Comprehensive Cancer Network (NCCN) working group listened to ideas on how restricting drugs could increase access, and how hospital consolidation increases costs. READ ARTICLE (free registration required)
ASCO Comments on U.S. Food and Drug Administration Biosimilars Approval Process
(ASCO in Action) Sept 28, 2018 - In a comment letter from ASCO President Monica M. Bertagnolli, MD, FACS, FASCO, to the Food and Drug Administration (FDA) Commissioner Scott Gottlieb, the society expressed appreciation for FDA’s efforts to gather stakeholder perspectives on enhancing access to biologic cancer therapies and ensuring greater availability of biosimilars, while retaining a balance between innovation and competition. READ ARTICLE